The market resolves to Yes if the sponsor of GB-005 issues a press release stating that the Phase 3 trial met its co-primary endpoints on or before July 24, 2026. Otherwise No.
Resolves Yes if The market resolves to Yes if the sponsor of GB-005 issues a press release stating that the Phase 3 trial met its co-primary endpoints on or before July 24, 2026. Otherwise No.
Outcome verified from globipharma.com.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…